Form D · Biotechnology
ZUCHEM INC
Chicago, IL · CIK 0001229586
Offering snapshot reported Jun 6, 2017 · SEC filing
- Reported sold
- $125K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 25, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2017 | Initial | $125,000 | No comparison | 3 | SEC filing |
| Apr 16, 2013 | Initial | $150,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-288134
Source: Form D, filed Jun 6, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rajni Aneja | Executive |
| Grant Brewen | Director |
| Thomas Churchwell | Director |
| David Demirjian | Director, Executive |
| Nelson Levy | Director |
| James Mc Conoughey | Director |
| Douglas Stewart | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2225 West Harrison Street Suite F
Chicago, IL, 60612
Chicago, IL, 60612